NCT06642207
Effect of IL17 Inhibitor in Comparison With Anti-TNF in Patients With Ankylosing Spondylitis
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 1 with changes below, 1 re-verified with no change.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Effect of IL17 Inhibitor in comparison with Anti-TNFα on Platelet count
Timeframe: 6 months
Platelet count association with disease activity in patients with Ankylosing Spondylitis
Timeframe: 6 months
Arms and interventions
group A
group B
Diagnostic tests: CBC
Sites
1 site in 1 country
- Sohag university HospitalSohag, Egypt